Clopra-Yellow en es it fr

Clopra-Yellow Brand names, Clopra-Yellow Analogs

Clopra-Yellow Brand Names Mixture

  • No information avaliable

Clopra-Yellow Chemical_Formula


Clopra-Yellow RX_link

Clopra-Yellow fda sheet

Clopra-Yellow FDA

Clopra-Yellow msds (material safety sheet)

Clopra-Yellow MSDS

Clopra-Yellow Synthesis Reference

Thominet, U.S. Pat. 3,177,252 (1965)

Clopra-Yellow Molecular Weight

299.796 g/mol

Clopra-Yellow Melting Point

147.25 oC

Clopra-Yellow H2O Solubility

200 mg/L

Clopra-Yellow State


Clopra-Yellow LogP


Clopra-Yellow Dosage Forms

Liquid; Syrup; Tablet

Clopra-Yellow Indication

For the treatment of gastroesophageal reflux disease (GERD)

Clopra-Yellow Pharmacology

Metoclopramide, although chemically related to procainamide, does not possess local anesthetic or antiarrhythmic properties. Metoclopramide is used to enhance GI motility, to treat diabetic gastroparesis, as an antinauseant, and to facilitate intubation of the small bowel during radiologic examination. Metoclopramide may be used to treat chemotherapy-induced emesis and as a radiosensitizing agents in the treatment of non-small cell lung carcinoma and glioblastomas in the future.

Clopra-Yellow Absorption

Rapidly and well absorbed (oral bioavailability 80±15.5%).

Clopra-Yellow side effects and Toxicity

Oral, mouse LD50: 280 mg/kg. Signs of overdose include drowsiness, disorientation, and extrapyramidal reactions.

Clopra-Yellow Patient Information

Clopra-Yellow Organisms Affected

Humans and other mammals